Reuters logo
CORRECTED-BRIEF-Arena Pharmaceuticals qtrly loss per share $0.11 (Feb 27)
February 28, 2014 / 2:10 PM / 4 years ago

CORRECTED-BRIEF-Arena Pharmaceuticals qtrly loss per share $0.11 (Feb 27)

(Corrects second bullet in Feb 27 item to say the company expects revenue of $9 mln from amortization of collaboration payments in 2014, not total revenue. Arena did not forecast total revenue) Feb 27 (Reuters) - Arena Pharmaceuticals Inc : * Provides corporate update and reports fourth quarter and full year 2013 financial results * Sees FY 2014 revenue of about $9 million from amortization of upfront payments from existing collaborations * Qtrly total revenues $6.5 million versus $1.9 million * Qtrly loss per share $0.11 * Q4 earnings per share view $0.02, revenue view $35.5 million -- Thomson Reuters I/B/E/S * FY 2014 revenue view $55.2 million -- Thomson Reuters I/B/E/S * Source text for Eikon * Further company coverage

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below